Results 121 to 130 of about 24,428 (246)

Outcome 1 year after ICH: Data from the Tranexamic acid for IntraCerebral Haemorrhage 2 (TICH-2) trial

open access: yes
Introduction: The Tranexamic acid for IntraCerebral Haemorrhage-2 (TICH-2) trial reported no significant improvement in death and dependency at day 90 despite reductions in haematoma expansion, early neurological deterioration and early death.
Woodhouse, Lisa J   +10 more
core   +1 more source

Tranexamic acid therapy for heavy menstrual bleeding

open access: yes, 2011
Introduction: Heavy menstrual bleeding (HMB, also known as menorrhagia) is an important health problem that interferes with women's quality of life. It is one of the most common reasons why women are seen by their family doctors in primary care and is a ...
Wedisinghe, L.   +3 more
core   +1 more source

Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery

open access: yes, 2017
BACKGROUND: Tranexamic acid reduces the risk of bleeding among patients undergoing cardiac surgery, but it is unclear whether this leads to improved outcomes.
?, ?
core   +1 more source

Clinical predictors of postpartum vaginal and vulvar hematomas and the need for surgical treatment

open access: yesPregnancy, Volume 2, Issue 4, July 2026.
Abstract Objective To identify risk factors for postpartum vaginal or vulvar hematoma and to determine clinical predictors of surgical intervention. Study design A retrospective matched case‐control study was conducted at a tertiary, university‐affiliated center (2012–2024).
Itai Atar   +5 more
wiley   +1 more source

Safety profile of tranexamic acid during and after caesarean section

open access: yes, 2016
Introduction: Delivery by caesarean section can cause many complications. The most common complications documented are primary and secondary postpartum hemorrhage.
Agrawal, Usha, Shrivastava, Preshant
core   +1 more source

Treatment of Melasma with Tranexamic Acid Essence Combined with Iontophoresis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

open access: yes
Linghong Guo,1,2 Xu Liu,1,2 Qingfeng Liu,1,2 Xiaoqin Xie,1,2 Xian Jiang1,2 1Department of Dermatology, West China Hospital, Sichuan University, Chengdu, People’s Republic of China; 2Laboratory of Dermatology, Clinical Institute of Inflammation and ...
Liu X, Guo L, Xie X, Jiang X, Liu Q
core  

General Anaesthesia Versus Spinal Anaesthesia for Outpatient Total Hip and Knee Arthroplasty: A Randomised Trial Protocol

open access: yesActa Anaesthesiologica Scandinavica, Volume 70, Issue 6, July 2026.
ABSTRACT Introduction Same‐day discharge after primary total hip arthroplasty (THA) and total knee arthroplasty (TKA) is increasing, but the optimal anaesthetic technique for outpatient pathways remains uncertain. Neuraxial anaesthesia is widely recommended based on observational evidence, whereas fast‐track programmes using short‐acting total ...
Erik Noppa   +6 more
wiley   +1 more source

Retropubic hemorrhage following Midurethral sling surgery: Diagnosis, clinical challenges, and management

open access: yesActa Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 7, Page 1344-1349, July 2026.
Retropubic hemorrhage after TVT surgery, though rare, is a serious complication—we outline a management strategy emphasizing timely diagnosis and tailored treatment to reduce morbidity. Abstract Mid‐urethral slings (MUS) such as tension‐free vaginal tape (TVT) are the established gold standard surgical approach for treating stress urinary incontinence (
Greta Lisa Carlin   +5 more
wiley   +1 more source

Tranexamic acid in subarachnoid hemorrhage. A double-blind study.

open access: yes, 1979
The effects of intravenous tranexamic acid were compared with placebo in 64 patients with subarachnoid hemorrhage. A double-blind procedure was used.
M Kaste, M Ramsay
core   +1 more source

Benzbromarone as a Novel Candidate for Preventing Alzheimer's Disease: Evidence From Real‐World Data Screening and in Vitro Validation

open access: yesClinical and Translational Science, Volume 19, Issue 7, July 2026.
Drug repositioning analysis identifies candidate therapeutic agents for Alzheimer’s diseaseand supports further mechanistic and translational investigation. ABSTRACT Drug development for Alzheimer's disease (AD) remains challenging, with only a 0.4% success rate from Phase I trials to regulatory approval.
Sho Sakagami   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy